gefitinib has been researched along with hederagenin in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (hederagenin) | Trials (hederagenin) | Recent Studies (post-2010) (hederagenin) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 131 | 0 | 89 |
| Protein | Taxonomy | gefitinib (IC50) | hederagenin (IC50) |
|---|---|---|---|
| Tissue factor | Homo sapiens (human) | 0.0002 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 0.8913 | |
| Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.8019 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Cheng, YY; Duan, HQ; Goto, M; Huang, KY; Lee, KH; Ling, Y; Liu, YL; Morris-Natschke, SL; Tong, XH; Yang, PC; Yang, SL | 1 |
1 other study(ies) available for gefitinib and hederagenin
| Article | Year |
|---|---|
Discovery of an Oleanolic Acid/Hederagenin-Nitric Oxide Donor Hybrid as an EGFR Tyrosine Kinase Inhibitor for Non-Small-Cell Lung Cancer.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Design; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Mutation; Nitric Oxide; Nitric Oxide Donors; Oleanolic Acid; Protein Kinase Inhibitors | 2019 |